Issues in prostate cancer: An update and review of screening and treatment options

Bernard Karnath, Gabriel Rodriguez

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Prostate cancer is the most common cancer detected in men and the second leading cause of all cancer deaths in men. It remains curable if diagnosed and treated at an early stage. Though screening tests are available, there remains substantial disagreement among various expert organizations as to the recommended prostate cancer screening guidelines for men Such controversy exists because it is difficult to determine whether early cancer detection translates into a decreased mortality rate. While intervention with radical prostatectomy of early-stage prostate cancer may reduce disease-specific mortality, it may not reduce overall mortality. In this cohort of patients, comorbid illnesses play a key role, and death due to causes other than prostate cancer occurs in a significant percentage of patients with early-stage prostate cancer. As a result, life expectancy and comorbidities of each individual be taken into consideration when deciding whether or not to screen and/or treat localized prostate cancer. This article reviews the issues in prostate cancer screening and the latest treatment options available for the various stages of prostate cancer.

Original languageEnglish (US)
Pages (from-to)391-400
Number of pages10
JournalAdvanced Studies in Medicine
Volume3
Issue number7
StatePublished - Jul 1 2003

Fingerprint

Prostatic Neoplasms
Early Detection of Cancer
Therapeutics
Mortality
Prostatectomy
Life Expectancy
Comorbidity
Neoplasms
Organizations
Guidelines

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Issues in prostate cancer : An update and review of screening and treatment options. / Karnath, Bernard; Rodriguez, Gabriel.

In: Advanced Studies in Medicine, Vol. 3, No. 7, 01.07.2003, p. 391-400.

Research output: Contribution to journalArticle

@article{43df8a71af874308af7aaeadd9b2d540,
title = "Issues in prostate cancer: An update and review of screening and treatment options",
abstract = "Prostate cancer is the most common cancer detected in men and the second leading cause of all cancer deaths in men. It remains curable if diagnosed and treated at an early stage. Though screening tests are available, there remains substantial disagreement among various expert organizations as to the recommended prostate cancer screening guidelines for men Such controversy exists because it is difficult to determine whether early cancer detection translates into a decreased mortality rate. While intervention with radical prostatectomy of early-stage prostate cancer may reduce disease-specific mortality, it may not reduce overall mortality. In this cohort of patients, comorbid illnesses play a key role, and death due to causes other than prostate cancer occurs in a significant percentage of patients with early-stage prostate cancer. As a result, life expectancy and comorbidities of each individual be taken into consideration when deciding whether or not to screen and/or treat localized prostate cancer. This article reviews the issues in prostate cancer screening and the latest treatment options available for the various stages of prostate cancer.",
author = "Bernard Karnath and Gabriel Rodriguez",
year = "2003",
month = "7",
day = "1",
language = "English (US)",
volume = "3",
pages = "391--400",
journal = "Advanced Studies in Medicine",
issn = "1530-3004",
publisher = "Galen Publishing LLC",
number = "7",

}

TY - JOUR

T1 - Issues in prostate cancer

T2 - An update and review of screening and treatment options

AU - Karnath, Bernard

AU - Rodriguez, Gabriel

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Prostate cancer is the most common cancer detected in men and the second leading cause of all cancer deaths in men. It remains curable if diagnosed and treated at an early stage. Though screening tests are available, there remains substantial disagreement among various expert organizations as to the recommended prostate cancer screening guidelines for men Such controversy exists because it is difficult to determine whether early cancer detection translates into a decreased mortality rate. While intervention with radical prostatectomy of early-stage prostate cancer may reduce disease-specific mortality, it may not reduce overall mortality. In this cohort of patients, comorbid illnesses play a key role, and death due to causes other than prostate cancer occurs in a significant percentage of patients with early-stage prostate cancer. As a result, life expectancy and comorbidities of each individual be taken into consideration when deciding whether or not to screen and/or treat localized prostate cancer. This article reviews the issues in prostate cancer screening and the latest treatment options available for the various stages of prostate cancer.

AB - Prostate cancer is the most common cancer detected in men and the second leading cause of all cancer deaths in men. It remains curable if diagnosed and treated at an early stage. Though screening tests are available, there remains substantial disagreement among various expert organizations as to the recommended prostate cancer screening guidelines for men Such controversy exists because it is difficult to determine whether early cancer detection translates into a decreased mortality rate. While intervention with radical prostatectomy of early-stage prostate cancer may reduce disease-specific mortality, it may not reduce overall mortality. In this cohort of patients, comorbid illnesses play a key role, and death due to causes other than prostate cancer occurs in a significant percentage of patients with early-stage prostate cancer. As a result, life expectancy and comorbidities of each individual be taken into consideration when deciding whether or not to screen and/or treat localized prostate cancer. This article reviews the issues in prostate cancer screening and the latest treatment options available for the various stages of prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=0041376452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041376452&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0041376452

VL - 3

SP - 391

EP - 400

JO - Advanced Studies in Medicine

JF - Advanced Studies in Medicine

SN - 1530-3004

IS - 7

ER -